Date of Award
1-1-2023
Document Type
Thesis
Degree Name
M.S. in Pharmaceutical Science
First Advisor
Michael A. Repka
Second Advisor
Dr. Walter Chambliss
Third Advisor
Eman Ashour
School
University of Mississippi
Relational Format
dissertation/thesis
Abstract
Fenofibrate (FNB) is a lipid-lowering medication used to treat hyperlipidemia that is practically insoluble in Water, leading to reduced absorption gastrointestinal tract. Complexation and lyophilization are performed and studied to enhance the solubility of the FNB in gastric fluid and increase its dissolution rate. The present study was intended to enhance the dissolution rate of Fenofibrate using complexation with hydroxy propyl β-cyclodextrin (HPβCD). Complexes of Fenofibrate with HPβCD were prepared in a 1:1 ratio by lyophilization. Differential Scanning Calorimetry, and Fourier-Transform Infrared spectroscopy, are used to characterize the solid state of a complex. Investigations of the physical properties of tablets manufactured by direct compression are evaluated, such as hardness (6.6 kp), friability (<1%), weight variation, and disintegration, to evaluate the percentage of drug content in the HPβCD complex. The rate of dissolution of Fenofibrate was increased in tablets containing the HPβCD complex, disintegrating agents, and other excipients. Moreover, formulations showed their highest release (97.77%) for the tablets formed by Complex 1:1 (fenofibrate: HP β-Cyclodextrin) with CCS (15 mg) disintegrating agent. Complexation with HPβCD can be used as a useful tool for the enhancement of the dissolution of Fenofibrate.
Recommended Citation
Soni, Krishna, "Formulation and Evaluation of Fenofibrate-HPꞵCD Tablets Using the Freeze-Drying Method" (2023). Electronic Theses and Dissertations. 2581.
https://egrove.olemiss.edu/etd/2581